retatrutide triple agonist Peptides Explained: Retatrutide, GLP-3, and the Future of Metabolic Research What Is Retatrutide? Complete Research

Scientific Data: In the OASIS 4 trial, 74% of participants experienced at least one gastrointestinal side effect

Mounjaro is a weekly injectable weight-loss drug for adults with obesity or overweight plus another weight-related condition

In preclinical models, catestatin exhibits anti-inflammatory, antihypertensive, and metabolic effects, and reduced circulating levels have been associated with hypertension, obesity, and insulin resistance (Mahata et al., 1997)

This phenomenon has been coined Ozempic babies on social media and news outlets, and also refers to the increased fertility of female patients using GLP-1 medications